The influence of allogenic blood transfusion in patients having free-flap primary surgery for oral and oropharyngeal squamous cell carcinoma

T. Szakmany, M. Dodd, G. Dempsey, D. Lowe, J. Brown, E. Vaughan, S. Rogers

    Research output: Contribution to journalArticle

    38 Citations (Scopus)

    Abstract

    The influence of perioperative blood transfusion in oral and oropharyngeal squamous cell carcinoma remains uncertain. It is believed that blood transfusion downregulates the immune system and may have an influence on cancer recurrence and survival. In all, 559 consecutive patients undergoing primary surgery for oral and oropharyngeal squamous cell carcinoma between 1992 and 2002 were included in this study. Known prognostic variables along with transfusion details were obtained from head and neck cancer and blood transfusion service databases, respectively. Adjusting for relevant prognostic factors in Cox regression, the hazard ratio for patients having 3 or more transfused units relative to those not transfused was 1.52 (95% confidence interval (CI) 0.93-2.47) for disease-specific and 1.52 (95% CI 1.05-2.22) for overall mortality. Blood transfusion of 3 or more units might confer a worse prognosis in patients undergoing primary surgery for oral and oropharyngeal squamous cell carcinoma. Therefore, every effort should be made to limit the amount of blood transfused to the minimum requirement
    Original languageEnglish
    Pages (from-to)647-653
    JournalBritish Journal of Cancer
    Volume94
    Issue number5
    Publication statusPublished - Mar 2006

    Fingerprint Dive into the research topics of 'The influence of allogenic blood transfusion in patients having free-flap primary surgery for oral and oropharyngeal squamous cell carcinoma'. Together they form a unique fingerprint.

  • Cite this

    Szakmany, T., Dodd, M., Dempsey, G., Lowe, D., Brown, J., Vaughan, E., & Rogers, S. (2006). The influence of allogenic blood transfusion in patients having free-flap primary surgery for oral and oropharyngeal squamous cell carcinoma. British Journal of Cancer, 94(5), 647-653.